Form 8-K - Current report:
SEC Accession No. 0001104659-24-121533
Filing Date
2024-11-21
Accepted
2024-11-21 16:14:59
Documents
14
Period of Report
2024-11-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428967d1_8k.htm   iXBRL 8-K 27705
2 EXHIBIT 99.1 tm2428967d1_ex99-1.htm EX-99.1 54931
  Complete submission text file 0001104659-24-121533.txt   267333

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA camp-20241121.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE camp-20241121_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE camp-20241121_pre.xml EX-101.PRE 22357
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2428967d1_8k_htm.xml XML 3826
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42365 | Film No.: 241484536
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)